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Objectives: Laboratory tests are now being used to identify seropositive cases in
patients suspected of having a Lyme borreliosis (LB) infection. From 2005 to
2009, we analyzed the serological and epidemiological characteristics of 53 LB
positive cases in Korea using immunoblot assay.
Methods: During the five-year study period, a total of 1897 serum samples from
suspected LB cases were referred to us for further laboratory diagnosis. The
bacterial strains Borrelia afzeli pKo, Borrelia garinii 935T and Borrelia burg-
dorferi B31 were used for indirect immunofluorescent antibody assay. Immuno-
blot assay was performed using the recomBlot Borrelia.
Results: Based on the information from the clinicians, the main symptoms of LB
infection were rash and fever (66.0%), neurological symptoms (30.2%), and
arthritis (5.7%). Of the 53 cases, 16 (30.2%) were infected abroad and the
remaining 37 cases (69.8%) were suspected to have been infected in Korea.
Immunoblot assays detected high levels of the antigens p41 (FlaB) of B. burg-
dorferi and OspC of B. garinii in infected samples.
Conclusions: The causative bacteria of LB were not isolated from humans yet but
from vector ticks and rodents in Korea, and a few cases were reported with
serological diagnosis. Our results suggest that LB is present in all areas of Korea
and indicate that B. garinii and B. burgdorferi may be the predominant bacteria
in patients with LB. However, further studies are needed to isolate and identify
the causative bacteria for LB in patients.1. Introduction
Lyme borreliosis (LB) is an infectious disease
transmitted by Ixodes spp. ticks and caused by theibuted under the terms o
y-nc/3.0) which permits unr
is properly cited.
ributed equally to this work.
ol and Prevention. Publishespirochete bacteria Borrelia burgdorferi sensu lato.
These bacteria are classified into three human patho-
gens, B. burgdorferi sensu stricto, Borrelia afzelii and
Borrelia garinii. It has been reported that thef the Creative Commons Attribution Non-Commercial License
estricted non-commercial use, distribution, and reproduction in
d by Elsevier. All rights reserved.
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on the region [1,2].
In 1993, B. burgdorferi and B. garinii were isolated
from Ixodes persulcatus and Apodemus agarius
captured in the Chungcheongbuk and Gangwon prov-
inces in Korea [3]. B. burgdorferi and B. afzelii were
also isolated from I. persulcatus, I. nipponesis,
I. granulatus and A. agarius captured in Gangwon and
Jeollanam provinces [3]. The causative bacteria have
not yet been isolated from humans in Korea; however,
clinical cases for which a diagnosis was made based on
serological and molecular findings have recently been
reported [4].
An initial symptom of LB is erythema chronicum
migrans, a rash formed at the site of the tick bite. Other
symptoms, such as fever, headache, myalgia and leth-
argy, are persistently present for several weeks. In the
absence of prompt antibiotic treatment, these symptoms
can lead to chronic myalgia, arthritis and impaired
visual acuity [1,2].
LB is characterized by the variability of clinical
symptoms and incidences. For a confirmatory diagnosis,
both clinical diagnosis and laboratory tests are required.
Laboratory tests for LB include indirect immunofluo-
rescent antibody assay (IFA) and immunoblot assay.
Immunoblot assay is also used to make a confirmatory
diagnosis in areas where LB is not an endemic disease
or where its incidence is relatively low [1,5]. In this
study, we used immunoblot assay to analyze the sero-
logical and epidemiological characteristics of 53 posi-
tive LB cases reported in Korea between 2005 and
2009.0
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Figure 1. Annual distribution (from 2005 to 2009) of the
number of serum samples from Lyme borreliosis suspected
case and the number that tested seropositive for Lyme
borreliosis.2. Materials and Methods
2.1. Sera
During the period from 2005 to 2009, when a LB
case was suspected, serum samples were referred to us
for further laboratory diagnosis. Detailed information
on an important clinical marker for LB and on other
characteristic manifestations was obtained from the
attending clinicians.
2.2. Bacterial strains and culture media
The bacterial strains B. afzeli pKo, B. garinii
935T, and B. burgdorferi B31 were cultured in BSK
(Barbour-Stoenner-Kelly) -II medium (Sigma, USA)
for 7e14 days. The bacteria were harvested by
centrifugation and washed three times in PBS (pH
7.2). The bacteria were suspended at a concentration
of 2  108 cell/mL and used to prepare slides for IFA.
2.3. Indirect immunofluorescent antibody assay
The concentration of the cultured bacterial strains
was adjusted to approximately 2  106 cell/10 mL.
These bacterial strains were evenly distributed to an18-well spot slide glass and then dried. Following a 10-
minute fixation using acetone, the slides were preserved
at 70C until required.
The test serum was diluted by serial 2-fold dilutions
from a titer of 1:16 to 1:1024. 20 mL of the diluted
serum was placed in each well of an 18-well spot slide
glass and the slides were incubated in a humidified
chamber at 37C for 30 minutes. The wells were then
washed twice with PBS (pH 7.2) and once with distilled
water. FITC-conjugated anti-human immunoglobulin
(MP Biomedicals, Ohio, USA) was added and the slides
were incubated in a humidified chamber at 37C for
30 minutes. Using the same methods, the slides were
washed and then dried. The slides were treated with
a mounting solution to prepare them for microscopy.
Positive samples were defined as those in which the IgM
titer was 1:16 or the IgG titer was 1:256. Samples
with positive readings were subjected to immunoblot
assay.
2.4. Immunoblot assay
Immunoblot assay was performed using the recom-
Blot Borrelia test (Mikrogen, Neuried, Germany)
according to the manufacturer’s instructions. The test
serum was diluted using the reactant solution to a ratio
of 1:200 for IgG and 1:10 for IgM. The reaction was
performed at room temperature for 10e16 hours. The
strips were washed four times and then treated with
a peroxidase conjugate. When the color developed, the
strip was examined and the results were determined. The
recomBlot Borrelia immunoblot test can detect IgG and
IgM antibodies directed against B. burgdorferi using
recombinant antigens of B. burgdorferi, B. afzelii and
B. garinii like p100, VlsE, p39, OspA, OspC, p41 and
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Figure 2. Accumulated monthly distribution of confirmed Lyme borreliosis positive cases for the five years from 2005 to 2009.
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for each antigen are calculated. Scores of <4 points
were defined as negative, scores between 5 and 6 points
were border-line and scores >7 points were accepted as
positive.3. Results
Between 2005 and 2009, a total of 1897 serum
samples from suspected LB cases were referred to us for
further laboratory diagnosis. The number of tested
serum samples and the number of seropositive cases are
described in Figure 1. Between 2005 and 2009, the
number of suspected cases of LB (212, 226, 360, 434,
and 665) increased annually. The number of confirmed
positive cases was 2, 3, 23, 9, and 16, over the five years
studied. The accumulated monthly occurrence of
confirmed LB cases for the five years from 2005 to 2009
is shown in Figure 2. The highest number of confirmed
cases of LB was found in May, and no cases were seen
in January. The age and gender distribution of LB
positive cases is described in Table 1. Regarding these
cases, 50.9% were male and the 30e39 years age group
had the highest proportion.
Based on the clinicians’ information about cases, 16
of 53 cases (30.2%) were identified as having beenTable 1. Distribution of Lyme borreliosis positive cases
by gender and age, 2005e2009
No. of positive Percent (%)
Gender
Male 27 50.9
Female 26 49.1
Age (in yr)
NAa 6 11.3
>20 2 3.8
20e29 7 13.2
30e39 15 28.3
40e49 9 17.0
50e59 7 13.2
60e69 5 9.4
70 2 3.8
aNA Z data not available.infected outside Korea; seven of them (13.2%) were
infected in America, more than in any other country. The
remaining 37 cases (69.8%) were thought to have been
infected in Korea, because there was no history of travel
abroad. The regional distribution of the 37 domestic
cases of LB is shown in Figure 3. With 12 cases, Seoul
had the highest number of cases. The distribution in theFigure 3. Regional distribution of the 37 domestic Lyme
borreliosis positive cases, 2005e2009. The color of the
triangle indicates the year.
Table 2. A comparison of the symptoms with the immunoblot IgG and IgM positive categories from Lyme borreliosis positive
cases
Symptoms
No. of
positive
Rates of
positivity p100b VlsEb p41/bb p39b OspAb
OspCa,b
p41/gb p41/afbg b/af g
Skin rash, fever, pain 35 66.0 5, 14 8, 16 19, 23 3, 5 4, 4 5, 20 6, 13 5, 12 7, 12 5, 4
Neuropathy, paralysis,
meningoencephalitis
15 28.3 3, 4 1, 3 5, 11 0, 1 3, 1 4, 5 3, 2 3, 4 4, 4 5, 3
Arthritis, knee pain,
swelling
3 5.7 0, 1 0, 1 1, 1 0, 0 0, 0 0, 1 1, 1 1, 1 0, 1 0, 0
Total 53 100 30 22 43 10 12 34 21 23 23 16
aGenus specific recombinant antigens; gZ B. garinii; bZ B. burgdorferi; afZ B. afzelii; bThe numbers in the antigen column indicate the number of cases
in which IgG and IgM, separated by a comma, were detected.
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cheongbuk, Chungcheongnam, Gyeongsangbuk and
Gyeongsangnam, ranged from one to seven. Thus, it
appears that LB is present in many areas of Korea.
Twenty cases (37.3%) were known to have been bitten
by a tick; 15 cases (75.0%) were infected abroad and five
cases (25%) were bitten in Korea. The serologically
diagnosed positive cases presented with various symp-
toms that included fever, fatigue, vasculitis, arthritis,
neurological symptoms and meningitis; however, the
main symptoms were rash and fever (66.0%), neuro-
logical involvement (30.2%), and arthritis (5.7%).
We analyzed the characteristics of the LB positive sera
using an immunoblot assay and compared them to the
main symptoms (Table 2). An immunoblot assay of IgG
and IgM showed that antigen p41 (FlaB) of B. burgdor-
feri was detected at the highest frequency, the next
highest was antigen OspC of B. garinii and then p100. For
IgM, in early infection cases with symptoms like rashes
and fever, antigen p41 of B. burgdorferi was detected at
the highest frequency, followed by OspC of B. garinii.
Antigen p41 of B. burgdorferi was also detected at the
highest frequency in cases with neurological symptoms.
Thus, these cases were presumed to be infected with
B. burgdorferi and B. garinii. For cases with chronic
symptoms, a comparison of the results from the immu-
noblot assay could not be made, because there was not
enough data to determine the causative pathogen.4. Discussion
In the 1990s, the level of antibody titer for LB in cases
with fever was investigated and antibody-positive find-
ings were found in 8.1e9.2% of total cases. These results
suggested the possible presence of LB in Korea [6,7].
Comparative studies have also been conducted to
examine the seasonal endemic characteristics seen in
May and December and to examine diagnostic regimens.
The symptoms of Korean LB cases and their antigenic
characteristics have also been reported [6]. Thecharacteristics of positive LB cases in this study were
similar to the characteristics reported in previous studies.
Immunoblot assay results for the early infectious
stage of LB have shown that the p41 and OspC antigens
are the most powerful immunogens [1]. With the
progression of the disease, the OspA and OspB antigens
have been reported to be powerful immunogens in the
late stage of infection. In this study, the OspC and p41
antigen bands were predominantly observed for IgM
positive results. Further laboratory evaluations are
required for the early stage of LB. In Korea, it is
imperative that, to confirm the infection, suspected cases
are tested using diagnostic antibody titer and culture
tests in the early stage of infection. For the isolation and
identification of Borrelia spp., it is essential that, prior to
antibiotic treatment, blood samples of suspected cases
are referred for diagnosis based on the laboratory tests.
LB occurs worldwide, and it is one of the most
common etiologies of vector infections developed by
bacteria. The distribution of Borrelia spp. in ticks and
rodents captured in Gangwon, Jeollanam and Chung-
cheongbuk provinces has been examined and bacterial
strains such as B. burgdorferi and B. afzeli have been
isolated [3,8]. In Korea, the isolation of Borrelia spp.
from humans has not yet been reported; however, based
on cases of LB diagnosed both serologically and
genetically, the current status of the isolation of patho-
genic bacteria from the vector and the increased number
of cases referred to us for further laboratory diagnosis,
we assume that the number of ticks infected with LB is
increasing. Our diagnostic results of LB occurrence in
Korea imply that cases of LB are no longer restricted to
the regional areas previously identified. Indeed, it is
highly probable that LB has spread nationwide.Acknowledgements
This study was supported by an intramural grant
(4837-300-210-13) from the National Institute of
Health, Korea. The authors thank A-Ram Kee, Ju-Hyum
Lyme borreliosis in Korea, 2005e2009 33Kim and Kum-Ran Hong for their assistance with IFA
and immunoblot diagnosis.
References
1. Aguero-Rosenfeld ME, Wang G, Schwartz I, et al. Diagnosis of
lyme borreliosis. Clin Microbiol Rev 2005 Jul;18(3):484e509.
2. LoGiudice K, Ostfeld RS, Schmidt KA, et al. The ecology of
infectious disease: effects of host diversity and community
composition on Lyme borreliosis risk. Proc Natl Acad Sci USA
2003 Jan 21;100(2):567e71.
3. Kee SH, Hwang KJ, Oh HB, et al. Isolation and Identification of
Borrelia burgdorferi in Korea. J Korean Soc Microbiol 1994 Apr;
29(4):301e10.4. Choi YJ, Han SH, Park JM, et al. First molecular detection of
Borrelia afzelii in clinical samples in Korea. Microbiol Immunol
2007 Dec;51(12):1201e7.
5. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and
serological diagnosis of Lyme borreliosis. FEMS Immunol Med
Microbiol 2007 Feb;49(1):13e21.
6. Park KH, Lee SH, Jang WJ, et al. Serological and antigenic analysis
against Borrelia burgdorferi of febrile cases in Korea. J Korean Soc
Microbiol 1993 Oct;28(5):397e408.
7. Song JW, Baek LJ, Lee YJ, et al. Seroepidemiologic analysis of
acute febrile illness from Korea in 1996. J Korean Soc Virol 1998
Dec;28(4):377e82.
8. Park KH, Chang WH, Schwan TG. Identification and character-
ization of Lyme borreliosis spirochetes, Borrelia burgdorferi sensu
lato, isolated in Korea. J Clin Microbiol 1993 Jul;31(7):1831e7.
